Identification of RSV Fusion Protein Interaction Domains on the Virus Receptor, Nucleolin
Open Access
- 8 February 2021
- Vol. 13 (2), 261
- https://doi.org/10.3390/v13020261
Abstract
Nucleolin is an essential cellular receptor to human respiratory syncytial virus (RSV). Pharmacological targeting of the nucleolin RNA binding domain RBD1,2 can inhibit RSV infections in vitro and in vivo; however, the site(s) on RBD1,2 which interact with RSV are not known. We undertook a series of experiments designed to: document RSV-nucleolin co-localization on the surface of polarized MDCK cells using immunogold electron microscopy, to identify domains on nucleolin that physically interact with RSV using biochemical methods and determine their biological effects on RSV infection in vitro, and to carry out structural analysis toward informing future RSV drug development. Results of immunogold transmission and scanning electron microscopy showed RSV-nucleolin co-localization on the cell surface, as would be expected for a viral receptor. RSV, through its fusion protein (RSV-F), physically interacts with RBD1,2 and these interactions can be competitively inhibited by treatment with Palivizumab or recombinant RBD1,2. Treatment with synthetic peptides derived from two 12-mer domains of RBD1,2 inhibited RSV infection in vitro, with structural analysis suggesting these domains are potentially feasible for targeting in drug development. In conclusion, the identification and characterization of domains of nucleolin that interact with RSV provide the essential groundwork toward informing design of novel nucleolin-targeting compounds in RSV drug development.Keywords
This publication has 28 references indexed in Scilit:
- Identification of nucleolin as a cellular receptor for human respiratory syncytial virusNature Medicine, 2011
- Respiratory Syncytial Virus-Neutralizing Monoclonal Antibodies Motavizumab and Palivizumab Inhibit FusionJournal of Virology, 2010
- Solution structure of the RBD1,2 domains from human nucleolinJournal of Biomolecular NMR, 2010
- Structural basis of respiratory syncytial virus neutralization by motavizumabNature Structural & Molecular Biology, 2010
- Role of Nucleolin in Human Parainfluenza Virus Type 3 Infection of Human Lung Epithelial CellsJournal of Virology, 2004
- Interaction between Respiratory Syncytial Virus and Particulate Matter in Guinea Pig Alveolar MacrophagesAmerican Journal of Respiratory Cell and Molecular Biology, 2003
- The Anti-HIV Pentameric Pseudopeptide HB-19 Binds the C-terminal End of Nucleolin and Prevents Anchorage of Virus Particles in the Plasma Membrane of Target CellsOnline Journal of Public Health Informatics, 2002
- Respiratory Syncytial Virus with the Fusion Protein as Its only Viral Glycoprotein Is Less Dependent on Cellular Glycosaminoglycans for Attachment than Complete VirusVirology, 2002
- Palivizumab, a Humanized Respiratory Syncytial Virus Monoclonal Antibody, Reduces Hospitalization From Respiratory Syncytial Virus Infection in High-risk InfantsPEDIATRICS, 1998
- An improved procedure for immunoelectron microscopy: ultrathin plastic embedding of immunolabeled ultrathin frozen sections.Proceedings of the National Academy of Sciences of the United States of America, 1984